News | November 05, 2024
Lonza’s Synaffix collaborates with BigHat Biosciences for ML-designed ADC
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Greg was also central to the planning, design, and construction of this facility
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
Sun Pharma's Dadra facility receives OAI status from US FDA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
